Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Claris IPO.
August 20, 2024 12:46:00 PM
AST SpaceMobile is working to develop a space-based broadband network. Early investors who have maintained their positions have seen strong growth. The company isn't generating strong revenue yet ...
Published by : The Motley FoolAugust 27, 2024 3:30:00 AM
Sign up for the India Edition newsletter by Menaka Doshi � an insider's guide to the emerging economic powerhouse, and the billionaires and businesses behind its ...
Published by : Bloomberg L.P.August 26, 2024 1:11:00 PM
MBX Biosciences has added to the recent flurry of IPO filings. The biotech, which filed its paperwork weeks after raising $63.5 million privately, is seeking funding to take a would-be challenger ...
Published by : FierceBiotechSeptember 2, 2024 12:40:00 AM
In the U.S., 80 new initial public offerings rolled out from January through June, hauling in $17.8 billion in proceeds, according to EY's Global IPO Trends Q2 2024. The increase in IPOs hit 27% ...
Published by : U.S. News & World ReportSeptember 17, 2024 3:30:00 AM
Pune-based PN Gadgil sold its IPO in the price band of Rs 458-480 per share with a lot size of 31 shares, which was open for bidding between September 10 and September 12. Western Carriers India ...
Published by : Business TodayAugust 19, 2024 9:39:00 PM
Since the company's initial public offering (IPO) in 1999, the stock has risen nearly 300,000%! The majority of that gain occurred over the last 10 years as the advent of cloud computing increased ...
Published by : The Motley FoolAugust 23, 2024 5:16:00 PM
Cava priced its IPO at $22 per share, valuing the company at $2.5 billion. (Photo by Spencer Platt/Getty Images) When a company exceeds quarterly growth targets and raises guidance, its stock ...
Published by : ForbesAugust 27, 2024 12:50:00 PM
China�s Duality Biotherapeutics has filed (PDF) paperwork for a Hong Kong IPO, seeking an undisclosed sum to power a broad pipeline of antibody-drug conjugates toward approval. The filing ...
Published by : FierceBiotechAugust 29, 2024 5:23:00 PM
The new Nasdaq IPO Pulse Index functions as a leading indicator for the IPO Market by forecasting the direction of US IPO activity over the next six months. IPO activity rises and falls in cycles.
Published by : NasdaqAugust 27, 2024 3:35:00 PM
September is a popular time for companies to go public. This month�s stock-market volatility is putting some plans on ice. Companies weighing whether to make their stock-market debuts face a ...
Published by : Wall Street JournalSeptember 9, 2024 3:29:00 AM
A private company can raise capital by selling shares publicly to institutional investors and retail investors through an issuance of new stock, called an initial public offering (IPO).
Published by : InvestopediaAugust 31, 2024 11:56:00 AM
Orient Technologies is expected to announce its IPO share allotment status on Monday, August 26. The shares of Orient Technologies were subscribed 151.68 times. The Orient Technologies shares are ...
Published by : Business Insider IndiaIPO Listing Detail
Listing Date: Monday, December 20, 2010
BSE Scrip Code: 533288
Listing In: 'B' Group of Securities
ISIN: INE562G01018
Issue Price: Rs. 228.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share
Claris Lifesciences Ltd IPO allotment status is now available online.
Claris Lifesciences IPO was open on Nov 24, 2010 and closed on Dec 02, 2010. IPO of Claris was oversubscribed by 1.50 times (1.60 times in retail).
Claris Lifesciences Ltd (CLL) IPO finally subscribed 1.50 times on its closing day. Claris IPO was open on Nov 24, 2010 and closed today on Dec 02, 2010 for subscription.
Oversubscription detail
Qualified Institutional Buyers (QIBs): 1.31 Times
Non Institutional Investors: 2.03 Times
Retail Individual Investors (RIIs): 1.60 Times
Total: 1.50 Times
Alert:
Book Running Lead Manager to the issue has informed the Exchange that the CLARIS LIFESCIENCES LIMITED issue will close on 2 Dec, 2010 instead of the earlier closing day on 26 Nov, 2010.Post issue modification date has been revised to 3 Dec, 2010 instead of the earlier closing day on 27 Nov, 2010. Further price band has revised from 278/- to Rs. 293/- TO Rs. 228/- to Rs. 235/- per share
Claris Lifesciences Limited (CLL) is entering in the capital markets with an initial public offering, IPO of Rs. 300.00 Crore. The price band for the issue has been fixed at Rs 278/- at lower level and Rs 293/- at upper level.
Incorporated in 1994, Claris Lifesciences Limited (CLL) is an Ahmedabad based pharmaceutical company. Claris is the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Claris offers 113 products across multiple markets and therapeutic areas. All of these products are off-patent products.
The issue opens on Nov 24, 2010, and closes for subscription on Nov 26, 2010. The equity shares of the issue are proposed to be listed on the Bombay Stock Exchange (BSE).
The Claris IPO is proposed to open on November 24, 2010. The IPO application ends on December 2, 2010.
Retail investors can apply in the retail or non-institutional investor category from November 24, 2010 to December 2, 2010. The Claris IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Claris IPO will open for subscription on November 24, 2010. The public issue will close on December 2, 2010.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
